Literature DB >> 17415322

Ingestion of superwarfarin leading to coagulopathy: a case report and review of the literature.

Austin T Nelson1, Joshua D Hartzell, Kenneth More, Steven J Durning.   

Abstract

Superwarfarins are found in many pesticides, including D-con, Prufe I and II, Ramik, Talon-G, Ratak, and Contrac. Ingestion of can lead to significant morbidity and even mortality. Physicians need to consider this diagnosis in any patient presenting with coagulopathy of unclear etiology. We present a patient with superwarfarin-induced coagulopathy and review previous cases in adults in the literature. The patient is a 60-year-old man who presented to our medical center with painless hematuria. Laboratory studies revealed an elevated prothrombin time (PT) (42.5 seconds), partial thromboplastin time (PTT) (64.6 seconds), and international normalized ratio (INR) of 7. Liver-associated enzymes were normal, and complete blood cell count (CBC) showed no evidence of disseminated intravascular coagulation. Subsequent work-up included the absence of an inhibitor by mixing study and deficiencies of vitamin K-dependent coagulation factors. The patient's warfarin level was negative. A brodifacoum level was positive, confirming superwarfarin-induced coagulopathy. The patient is currently doing well with normal coagulation studies after receiving high doses of vitamin K for several weeks. The cause of his exposure to superwarfarin remains uncertain. Physicians need to be cognizant of this unusual cause of coagulopathy in adults. The appropriate diagnostic work-up and unique features of therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17415322      PMCID: PMC1868388     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  26 in total

1.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Jessica Youniss; S Rutherfoord Rose; Douglas Borys; Mary E May
Journal:  Am J Emerg Med       Date:  2003-09       Impact factor: 2.469

2.  Superwarfarin poisoning--a report of 4 cases.

Authors:  V Poovalingam; D G Kenoyer; R Mahomed; N Rapiti; F Bassa; P Govender
Journal:  S Afr Med J       Date:  2002-11

3.  2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  Toby L Litovitz; Wendy Klein-Schwartz; George C Rodgers; Daniel J Cobaugh; Jessica Youniss; Judith C Omslaer; Mary E May; Alan D Woolf; Blaine E Benson
Journal:  Am J Emerg Med       Date:  2002-09       Impact factor: 2.469

4.  Novel 4-hydroxycoumarin anticoagulants active against resistant rats.

Authors:  M R Hadler; R S Shadbolt
Journal:  Nature       Date:  1975-01-24       Impact factor: 49.962

5.  Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII.

Authors:  Silva Zupancić-Salek; Jasminka Kovacević-Metelko; Ivo Radman
Journal:  Blood Coagul Fibrinolysis       Date:  2005-06       Impact factor: 1.276

6.  2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Nicole Reid; Jessica Youniss; Anne Flanagan; Kathleen M Wruk
Journal:  Am J Emerg Med       Date:  2005-09       Impact factor: 2.469

7.  Acquired coagulopathy due to anticoagulant rodenticide poisoning.

Authors:  Mirjana Huić; Igor Francetić; Ivan Bakran; Viola Macolić-Sarinić; Marinko Bilusić
Journal:  Croat Med J       Date:  2002-10       Impact factor: 1.351

8.  Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.

Authors:  B K Park; I A Choonara; B P Haynes; A M Breckenridge; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 9.  The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review.

Authors:  Douglas L Riegert-Johnson; Gerald W Volcheck
Journal:  Ann Allergy Asthma Immunol       Date:  2002-10       Impact factor: 6.347

10.  Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy.

Authors:  Ben T Tsutaoka; Michael Miller; Stacey M Fung; Manish M Patel; Kent R Olson
Journal:  Pharmacotherapy       Date:  2003-09       Impact factor: 4.705

View more
  4 in total

1.  Coagulation Disorder following Red Clover (Trifolium Pratense) Misuse: a Case Report.

Authors:  Sahar Karimpour-Reihan; Elnaz Firuzei; Malihe Khosravi; Mahsa Abbaszade
Journal:  Adv J Emerg Med       Date:  2018-01-12

2.  Treatment of a long-acting anticoagulant rodenticide poisoning cohort with vitamin K1 during the maintenance period.

Authors:  Jianhai Long; Xiaobo Peng; Yuan Luo; Yawei Sun; Guodong Lin; Yongan Wang; Zewu Qiu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 3.  A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective.

Authors:  Valery V Wojciechowski; Daniela Calina; Konstantinos Tsarouhas; Alexander V Pivnik; Alexander A Sergievich; Vladimir V Kodintsev; Ekaterina A Filatova; Eren Ozcagli; Anca Oana Docea; Andreea Letitia Arsene; Eliza Gofita; Christina Tsitsimpikou; Aristidis M Tsatsakis; Kirill S Golokhvast
Journal:  Daru       Date:  2017-04-17       Impact factor: 3.117

4.  Superwarfarin Exposure: An Important Uncommon Cause of Painless Bleeding.

Authors:  Sreenath Kodali; Tara Rajendran; Ivan N Richard; Lakshmi Boyapati; Edward C C Wong; Boris Avezbakiyev
Journal:  J Hematol (Brossard)       Date:  2019-12-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.